Back to Search Start Over

Is Prenatal Screening for GBS Cost-Effective in the United States?

Source :
OB/GYN Clinical Alert. Dec2021, Vol. 38 Issue 8, p1-3. 3p.
Publication Year :
2021

Abstract

In this cost-effectiveness study, screening for group B streptococcus (GBS) at 36 0/7 to 37 6/7 weeks, with rescreening (if GBS results are negative after five weeks of initial screening), is the most cost-effective strategy. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
*MEDICAL screening
*STREPTOCOCCUS
*ANTIBIOTIC prophylaxis
*PENICILLIN
*COST effectiveness
*PRENATAL care
*GRAM-positive bacteria

Details

Language :
English
ISSN :
07438354
Volume :
38
Issue :
8
Database :
Academic Search Index
Journal :
OB/GYN Clinical Alert
Publication Type :
Academic Journal
Accession number :
153684768

Tools

Authors Abstract Subjects Details